Diagnóstico prenatal no invasivo: presente y futuro de mano de las nuevas tecnologías

Lo, 1997, Presence of fetal DNA in maternal plasma and serum, Lancet, 350, 485, 10.1016/S0140-6736(97)02174-0 Lo, 1998, Quantitative analysis of fetal DNA in maternal plasma and serum: implications for non-invasive prenatal diagnosis, Am J Hum Genet, 62, 768, 10.1086/301800 Bustamante-Aragones, 2008, Foetal sex determination in maternal blood from the seventh week of gestation and its role in diagnosing haemophilia in the foetuses of female carriers, Haemophilia, 14, 593, 10.1111/j.1365-2516.2008.01670.x Bianchi, 2004, Circulating fetal DNA: its origin and diagnostic potential-a review, Placenta, 25, S93, 10.1016/j.placenta.2004.01.005 Lun, 2008, Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma, Clin Chem, 54, 1664, 10.1373/clinchem.2008.111385 Liao, 2012, Prenatal assessment of fetal chromosomal and genetic disorders through maternal plasma DNA analysis, Pathology, 44, 69, 10.1097/PAT.0b013e32834e8e29 Chen, 2011, Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing, PLoS One, 6, e21791, 10.1371/journal.pone.0021791 Ehrich, 2011, Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting, Am J Obstet Gynecol, 204, 205.e1, 10.1016/j.ajog.2010.12.060 Palomaki, 2011, DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study, Genet Med, 13, 913, 10.1097/GIM.0b013e3182368a0e Palomaki, 2012, DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study, Genet Med, 10.1038/gim.2011.73 Lo, 2010, Maternal plasma DNA sequencing reveals the genome-wide genetics and mutational profile of the fetus, Sci Transl Med, 2, 61ra91, 10.1126/scitranslmed.3001720 Leon, 1997, Free DNA in the serum of cancer patients and the effect of therapy, Cancer Res, 37, 646 Chan, 2004, Size distributions of maternal and fetal DNA in maternal plasma, Clin Chem, 50, 88, 10.1373/clinchem.2003.024893 Dhallan, 2004, Methods to increase the percentage of free fetal DNA recovered from the maternal circulation, JAMA, 291, 1114, 10.1001/jama.291.9.1114 Zhang, 2008, Effect of formaldehyde treatment on the recovery of cell-free fetal DNA from maternal plasma at different processing times, Clin Chim Acta, 397, 60, 10.1016/j.cca.2008.07.017 Clausen, 2007, Improvement in fetal DNA extraction from maternal plasma. Evaluation of the NucliSens Magnetic Extraction system and the QIAamp DSP Virus Kit in comparison with the QIAamp DNA Blood Mini Kit, Prenat Diagn, 27, 6, 10.1002/pd.1605 Legler, 2008, Fetal DNA: strategies for optimal recovery, Methods Mol Biol, 444, 209, 10.1007/978-1-59745-066-9_16 Johnson, 2004, Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR, Clin Chem, 50, 516, 10.1373/clinchem.2003.024380 Finning, 2002, Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service, Transfusion, 42, 1079, 10.1046/j.1537-2995.2002.00165.x Minon, 2008, Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium, Transfusion, 48, 373 Gautier, 2005, Fetal RhD genotyping by maternal serum analysis: a two-year experience, Am J Obstet Gynecol, 192, 666, 10.1016/j.ajog.2004.10.632 Lo, 1998, Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma, N Engl J Med, 339, 1734, 10.1056/NEJM199812103392402 Faas, 1998, Detection of fetal RHD-specific sequences in maternal plasma, Lancet, 352, 1196, 10.1016/S0140-6736(05)60534-X Gonzalez-Gonzalez, 2003, Early Huntington disease prenatal diagnosis by maternal semi quantitative fluorescent-PCR, Neurology, 60, 1214, 10.1212/01.WNL.0000056084.13096.8A Gonzalez-Gonzalez, 2003, Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR, Prenat Diagn, 23, 232, 10.1002/pd.570 Gonzalez-Gonzalez, 2008, Improvement in strategies for the non-invasive prenatal diagnosis of Huntington disease, J Assist Reprod Genet, 25, 477, 10.1007/s10815-008-9256-8 Bustamante-Aragones, 2008, Prenatal diagnosis of Huntington disease in maternal plasma: direct and indirect study, Eur J Neurol, 15, 1338, 10.1111/j.1468-1331.2008.02312.x Amicucci, 2000, Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma, Clin Chem, 46, 301, 10.1093/clinchem/46.2.301 Meaney, 2009, Noninvasive prenatal diagnosis of early onset primary dystonia I in maternal plasma, Prenatal Diagnosis, 29, 1218, 10.1002/pd.2385 Li, 2004, Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma--case report, Prenat Diagn, 24, 896, 10.1002/pd.1030 Li, 2007, Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay, Prenat Diagn, 27, 11, 10.1002/pd.1608 Lim, 2010, Non-invasive prenatal detection of achondroplasia using circulating fetal DNA in maternal plasma, J Assist Reprod Genet, 28, 167, 10.1007/s10815-010-9489-1 Chitty, 2011, New aids for the non-invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell-free fetal DNA in maternal plasma, Ultrasound Obstet Gynecol, 37, 283, 10.1002/uog.8893 Smid, 2006, Correlation of fetal DNA in maternal plasma with Doppler status in pathological pregnancies, Prenat Diagn, 26, 785, 10.1002/pd.1504 Chiu, 2002, Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study, Clin Chem, 48, 778, 10.1093/clinchem/48.5.778 Ritzen, 2001, Prenatal dexamethasone treatment of fetuses at risk for congenital adrenal hyperplasia: benefits and concerns, Semin Neonatol, 6, 357, 10.1053/siny.2001.0071 New, 2001, Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies, J Clin Endocrinol Metab, 86, 5651, 10.1210/jc.86.12.5651 Tungwiwat, 2006, Development and application of a real-time quantitative PCR for prenatal detection of fetal alpha(0)-thalassemia from maternal plasma, Ann N Y Acad Sci, 1075, 103, 10.1196/annals.1368.013 Chiu, 2002, Prenatal exclusion of beta thalassaemia major by examination of maternal plasma, Lancet, 360, 998, 10.1016/S0140-6736(02)11086-5 Fucharoen, 2003, Prenatal detection of fetal hemoglobin E gene from maternal plasma, Prenat Diagn, 23, 393, 10.1002/pd.607 Papasavva, 2006, Noninvasive prenatal diagnostic assay for the detection of beta-thalassemia, Ann N Y Acad Sci, 1075, 148, 10.1196/annals.1368.020 Papasavva, 2008, Arrayed primer extension for the noninvasive prenatal diagnosis of beta-thalassemia based on detection of single nucleotide polymorphisms, Ann N Y Acad Sci, 1137, 302, 10.1196/annals.1448.029 Tungwiwat, 2007, Application of maternal plasma DNA analysis for noninvasive prenatal diagnosis of Hb E-beta-thalassemia, Transl Res, 150, 319, 10.1016/j.trsl.2007.06.006 Lun, 2008, Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma, Proc Nat Acad Sci, 105, 19920, 10.1073/pnas.0810373105 Li, 2009, Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited β-thalassemia point mutation by MALDI-TOF mass spectrometry, Fetal Diagn Ther, 25, 246, 10.1159/000223442 Chan, 2010, Detection of paternal alleles in maternal plasma for non-invasive prenatal diagnosis of beta-thalassemia: A feasibility study in southern Chinese, Eur J Obstet Gynecol Reprod Biol, 150, 28, 10.1016/j.ejogrb.2010.02.016 Lo, 2010, Noninvasive approaches to prenatal diagnosis of hemoglobinopathies using fetal DNA in maternal plasma, Hematol Oncol Clin North Am, 24, 1179, 10.1016/j.hoc.2010.08.007 Yi, 2010, Development of a pcr/ldr/capillary electrophoresis assay with potential for the detection of a beta-thalassemia fetal mutation in maternal plasma, J Matern Fetal Neonatal Med, 23, 920, 10.3109/14767050903387060 Gonzalez-Gonzalez, 2002, Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma, Prenat Diagn, 22, 946, 10.1002/pd.439 Nasis, 2004, Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis, Clinical Chemistry, 50, 694, 10.1373/clinchem.2003.025981 Bustamante-Aragones, 2008, New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma, J Cyst Fibros, 7, 505, 10.1016/j.jcf.2008.05.006 Bustamante-Aragones, 2008, Early noninvasive prenatal detection of a fetal CRB1 mutation causing Leber congenital amaurosis, Mol Vis, 14, 1388 Bustamante-Aragones, 2008, Prenatal diagnosis in maternal plasma of a fetal mutation causing propionic acidemia, Mol Genet Metab, 95, 101, 10.1016/j.ymgme.2008.05.006 Harton, 2011, ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening, Hum Reprod, 26, 14, 10.1093/humrep/deq229